ArticleResearch and reports in urology2025
Delayed Presentation of Mixed Testicular Tumor 19 Years After Orchiopexy: A Case Report and Literature Review.
Article in Research and reports in urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparison of Perioperative and Oncologic Outcomes Between Robotic and Open Retroperitoneal Lymph Node Dissection in Testicular Cancer: A Systematic Review and Meta-analysis.Annals of surgical oncology · 2026Pooled it
- Epidemiology, Etiopathogenesis, Diagnosis, and Treatment of Male Infertility-Current Trends and Future Directions: A Narrative Review.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Testicular cancer is a relatively rare malignancy, accounting for 1% of solid tumors in adult males and 5% of all urological tumors. Orchidopexy has been shown to lower the risk of testicular cancer, but it does not prevent it. Case Presentation: A 20-year-old adult male presented with a painful and palpable mass in his right testicle. The patient had orchidopexy at six months old but had been asymptomatic until his recent hospital visit. There was no previous history of cancer. Tumor markers including AFP and β-HCG were found to be elevated. Preoperative ultrasonograghy (USG) showed a solid and cystic mass of the right testis with increased vascularization. Following these findings, the patient underwent an orchidectomy. Histopathology examination revealed mixed type NSGCT of embryonal and choriocarcinoma. However, after completing four cycles of chemotherapy, a CT scan evaluation showed an enlarged mass in the abdomen, which was confirmed to be a mature teratoma. Conclusion: In patients with a history of cryptorchidism, orchidopexy does not rule out the possibility of testicular cancer. Orchidopexy did reduce the risk of seminoma, but not nonseminomatous germ cell tumor, which in our case continued to develop a growing teratoma on the abdomen. It is essential to conduct long-term monitoring of patients who have undergone orchiopexy due to their risk of developing testicular cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.